Prostate Cancer Diagnostics Market - Global Outlook and Forecast 2021-2027

March 2021 | 93 pages | ID: P2187727AD27EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Prostate Cancer Diagnostics in Global, including the following market information:

Global Prostate Cancer Diagnostics Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Prostate Cancer Diagnostics market was valued at 12880 million in 2020 and is projected to reach US$ 17210 million by 2027, at a CAGR of 7.5% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prostate Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Prostate Cancer Diagnostics Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Prostate Cancer Diagnostics Market Segment Percentages, By Type, 2020 (%)

• Tumor Biomarker Tests
• Imaging
• Biopsy
• Other

China Prostate Cancer Diagnostics Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Prostate Cancer Diagnostics Market Segment Percentages, By Application, 2020 (%)

• Age Below 55
• Age 55-75
• Age Above 75

Global Prostate Cancer Diagnostics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Prostate Cancer Diagnostics Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Prostate Cancer Diagnostics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Prostate Cancer Diagnostics Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• OPKO
• Genomic Health
• Abbott
• Beckman Coulter
• Siemens Healthcare
• bioMeriux
• Roche
• MDx Health
• DiaSorin
• Myriad Genetics
• Ambry Genetics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Prostate Cancer Diagnostics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Prostate Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PROSTATE CANCER DIAGNOSTICS OVERALL MARKET SIZE

2.1 Global Prostate Cancer Diagnostics Market Size: 2021 VS 2027
2.2 Global Prostate Cancer Diagnostics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Prostate Cancer Diagnostics Players in Global Market
3.2 Top Global Prostate Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Prostate Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Diagnostics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Prostate Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Diagnostics Players in Global Market
  3.6.1 List of Global Tier 1 Prostate Cancer Diagnostics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Prostate Cancer Diagnostics Market Size Markets, 2021 & 2027
  4.1.2 Tumor Biomarker Tests
  4.1.3 Imaging
  4.1.4 Biopsy
  4.1.5 Other
4.2 By Type - Global Prostate Cancer Diagnostics Revenue & Forecasts
  4.2.1 By Type - Global Prostate Cancer Diagnostics Revenue, 2016-2021
  4.2.2 By Type - Global Prostate Cancer Diagnostics Revenue, 2022-2027
  4.2.3 By Type - Global Prostate Cancer Diagnostics Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Prostate Cancer Diagnostics Market Size, 2021 & 2027
  5.1.2 Age Below
  5.1.3 Age 55-75
  5.1.4 Age Above
5.2 By Application - Global Prostate Cancer Diagnostics Revenue & Forecasts
  5.2.1 By Application - Global Prostate Cancer Diagnostics Revenue, 2016-2021
  5.2.2 By Application - Global Prostate Cancer Diagnostics Revenue, 2022-2027
  5.2.3 By Application - Global Prostate Cancer Diagnostics Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Prostate Cancer Diagnostics Market Size, 2021 & 2027
6.2 By Region - Global Prostate Cancer Diagnostics Revenue & Forecasts
  6.2.1 By Region - Global Prostate Cancer Diagnostics Revenue, 2016-2021
  6.2.2 By Region - Global Prostate Cancer Diagnostics Revenue, 2022-2027
  6.2.3 By Region - Global Prostate Cancer Diagnostics Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Prostate Cancer Diagnostics Revenue, 2016-2027
  6.3.2 US Prostate Cancer Diagnostics Market Size, 2016-2027
  6.3.3 Canada Prostate Cancer Diagnostics Market Size, 2016-2027
  6.3.4 Mexico Prostate Cancer Diagnostics Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Prostate Cancer Diagnostics Revenue, 2016-2027
  6.4.2 Germany Prostate Cancer Diagnostics Market Size, 2016-2027
  6.4.3 France Prostate Cancer Diagnostics Market Size, 2016-2027
  6.4.4 U.K. Prostate Cancer Diagnostics Market Size, 2016-2027
  6.4.5 Italy Prostate Cancer Diagnostics Market Size, 2016-2027
  6.4.6 Russia Prostate Cancer Diagnostics Market Size, 2016-2027
  6.4.7 Nordic Countries Prostate Cancer Diagnostics Market Size, 2016-2027
  6.4.8 Benelux Prostate Cancer Diagnostics Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Prostate Cancer Diagnostics Revenue, 2016-2027
  6.5.2 China Prostate Cancer Diagnostics Market Size, 2016-2027
  6.5.3 Japan Prostate Cancer Diagnostics Market Size, 2016-2027
  6.5.4 South Korea Prostate Cancer Diagnostics Market Size, 2016-2027
  6.5.5 Southeast Asia Prostate Cancer Diagnostics Market Size, 2016-2027
  6.5.6 India Prostate Cancer Diagnostics Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Prostate Cancer Diagnostics Revenue, 2016-2027
  6.6.2 Brazil Prostate Cancer Diagnostics Market Size, 2016-2027
  6.6.3 Argentina Prostate Cancer Diagnostics Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Prostate Cancer Diagnostics Revenue, 2016-2027
  6.7.2 Turkey Prostate Cancer Diagnostics Market Size, 2016-2027
  6.7.3 Israel Prostate Cancer Diagnostics Market Size, 2016-2027
  6.7.4 Saudi Arabia Prostate Cancer Diagnostics Market Size, 2016-2027
  6.7.5 UAE Prostate Cancer Diagnostics Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 OPKO
  7.1.1 OPKO Corporate Summary
  7.1.2 OPKO Business Overview
  7.1.3 OPKO Prostate Cancer Diagnostics Major Product Offerings
  7.1.4 OPKO Prostate Cancer Diagnostics Revenue in Global (2016-2021)
  7.1.5 OPKO Key News
7.2 Genomic Health
  7.2.1 Genomic Health Corporate Summary
  7.2.2 Genomic Health Business Overview
  7.2.3 Genomic Health Prostate Cancer Diagnostics Major Product Offerings
  7.2.4 Genomic Health Prostate Cancer Diagnostics Revenue in Global (2016-2021)
  7.2.5 Genomic Health Key News
7.3 Abbott
  7.3.1 Abbott Corporate Summary
  7.3.2 Abbott Business Overview
  7.3.3 Abbott Prostate Cancer Diagnostics Major Product Offerings
  7.3.4 Abbott Prostate Cancer Diagnostics Revenue in Global (2016-2021)
  7.3.5 Abbott Key News
7.4 Beckman Coulter
  7.4.1 Beckman Coulter Corporate Summary
  7.4.2 Beckman Coulter Business Overview
  7.4.3 Beckman Coulter Prostate Cancer Diagnostics Major Product Offerings
  7.4.4 Beckman Coulter Prostate Cancer Diagnostics Revenue in Global (2016-2021)
  7.4.5 Beckman Coulter Key News
7.5 Siemens Healthcare
  7.5.1 Siemens Healthcare Corporate Summary
  7.5.2 Siemens Healthcare Business Overview
  7.5.3 Siemens Healthcare Prostate Cancer Diagnostics Major Product Offerings
  7.5.4 Siemens Healthcare Prostate Cancer Diagnostics Revenue in Global (2016-2021)
  7.5.5 Siemens Healthcare Key News
7.6 bioMeriux
  7.6.1 bioMeriux Corporate Summary
  7.6.2 bioMeriux Business Overview
  7.6.3 bioMeriux Prostate Cancer Diagnostics Major Product Offerings
  7.6.4 bioMeriux Prostate Cancer Diagnostics Revenue in Global (2016-2021)
  7.6.5 bioMeriux Key News
7.7 Roche
  7.7.1 Roche Corporate Summary
  7.7.2 Roche Business Overview
  7.7.3 Roche Prostate Cancer Diagnostics Major Product Offerings
  7.4.4 Roche Prostate Cancer Diagnostics Revenue in Global (2016-2021)
  7.7.5 Roche Key News
7.8 MDx Health
  7.8.1 MDx Health Corporate Summary
  7.8.2 MDx Health Business Overview
  7.8.3 MDx Health Prostate Cancer Diagnostics Major Product Offerings
  7.8.4 MDx Health Prostate Cancer Diagnostics Revenue in Global (2016-2021)
  7.8.5 MDx Health Key News
7.9 DiaSorin
  7.9.1 DiaSorin Corporate Summary
  7.9.2 DiaSorin Business Overview
  7.9.3 DiaSorin Prostate Cancer Diagnostics Major Product Offerings
  7.9.4 DiaSorin Prostate Cancer Diagnostics Revenue in Global (2016-2021)
  7.9.5 DiaSorin Key News
7.10 Myriad Genetics
  7.10.1 Myriad Genetics Corporate Summary
  7.10.2 Myriad Genetics Business Overview
  7.10.3 Myriad Genetics Prostate Cancer Diagnostics Major Product Offerings
  7.10.4 Myriad Genetics Prostate Cancer Diagnostics Revenue in Global (2016-2021)
  7.10.5 Myriad Genetics Key News
7.11 Ambry Genetics
  7.11.1 Ambry Genetics Corporate Summary
  7.11.2 Ambry Genetics Business Overview
  7.11.3 Ambry Genetics Prostate Cancer Diagnostics Major Product Offerings
  7.11.4 Ambry Genetics Prostate Cancer Diagnostics Revenue in Global (2016-2021)
  7.11.5 Ambry Genetics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Prostate Cancer Diagnostics Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Diagnostics Market Drivers in Global Market
Table 3. Prostate Cancer Diagnostics Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Diagnostics in Global Market
Table 5. Top Prostate Cancer Diagnostics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Prostate Cancer Diagnostics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Prostate Cancer Diagnostics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Prostate Cancer Diagnostics Product Type
Table 9. List of Global Tier 1 Prostate Cancer Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Prostate Cancer Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Prostate Cancer Diagnostics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Prostate Cancer Diagnostics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Prostate Cancer Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Prostate Cancer Diagnostics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Prostate Cancer Diagnostics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Prostate Cancer Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Prostate Cancer Diagnostics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Prostate Cancer Diagnostics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Prostate Cancer Diagnostics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Prostate Cancer Diagnostics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Prostate Cancer Diagnostics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Prostate Cancer Diagnostics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Prostate Cancer Diagnostics Revenue, (US$, Mn), 2022-2027
Table 30. OPKO Corporate Summary
Table 31. OPKO Prostate Cancer Diagnostics Product Offerings
Table 32. OPKO Prostate Cancer Diagnostics Revenue (US$, Mn), (2016-2021)
Table 33. Genomic Health Corporate Summary
Table 34. Genomic Health Prostate Cancer Diagnostics Product Offerings
Table 35. Genomic Health Prostate Cancer Diagnostics Revenue (US$, Mn), (2016-2021)
Table 36. Abbott Corporate Summary
Table 37. Abbott Prostate Cancer Diagnostics Product Offerings
Table 38. Abbott Prostate Cancer Diagnostics Revenue (US$, Mn), (2016-2021)
Table 39. Beckman Coulter Corporate Summary
Table 40. Beckman Coulter Prostate Cancer Diagnostics Product Offerings
Table 41. Beckman Coulter Prostate Cancer Diagnostics Revenue (US$, Mn), (2016-2021)
Table 42. Siemens Healthcare Corporate Summary
Table 43. Siemens Healthcare Prostate Cancer Diagnostics Product Offerings
Table 44. Siemens Healthcare Prostate Cancer Diagnostics Revenue (US$, Mn), (2016-2021)
Table 45. bioMeriux Corporate Summary
Table 46. bioMeriux Prostate Cancer Diagnostics Product Offerings
Table 47. bioMeriux Prostate Cancer Diagnostics Revenue (US$, Mn), (2016-2021)
Table 48. Roche Corporate Summary
Table 49. Roche Prostate Cancer Diagnostics Product Offerings
Table 50. Roche Prostate Cancer Diagnostics Revenue (US$, Mn), (2016-2021)
Table 51. MDx Health Corporate Summary
Table 52. MDx Health Prostate Cancer Diagnostics Product Offerings
Table 53. MDx Health Prostate Cancer Diagnostics Revenue (US$, Mn), (2016-2021)
Table 54. DiaSorin Corporate Summary
Table 55. DiaSorin Prostate Cancer Diagnostics Product Offerings
Table 56. DiaSorin Prostate Cancer Diagnostics Revenue (US$, Mn), (2016-2021)
Table 57. Myriad Genetics Corporate Summary
Table 58. Myriad Genetics Prostate Cancer Diagnostics Product Offerings
Table 59. Myriad Genetics Prostate Cancer Diagnostics Revenue (US$, Mn), (2016-2021)
Table 60. Ambry Genetics Corporate Summary
Table 61. Ambry Genetics Prostate Cancer Diagnostics Product Offerings
Table 62. Ambry Genetics Prostate Cancer Diagnostics Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Prostate Cancer Diagnostics Segment by Type
Figure 2. Prostate Cancer Diagnostics Segment by Application
Figure 3. Global Prostate Cancer Diagnostics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Diagnostics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Prostate Cancer Diagnostics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Diagnostics Revenue in 2020
Figure 8. By Type - Global Prostate Cancer Diagnostics Revenue Market Share, 2016-2027
Figure 9. By Application - Global Prostate Cancer Diagnostics Revenue Market Share, 2016-2027
Figure 10. By Region - Global Prostate Cancer Diagnostics Revenue Market Share, 2016-2027
Figure 11. By Country - North America Prostate Cancer Diagnostics Revenue Market Share, 2016-2027
Figure 12. US Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Prostate Cancer Diagnostics Revenue Market Share, 2016-2027
Figure 16. Germany Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 17. France Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Prostate Cancer Diagnostics Revenue Market Share, 2016-2027
Figure 24. China Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 28. India Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Prostate Cancer Diagnostics Revenue Market Share, 2016-2027
Figure 30. Brazil Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Prostate Cancer Diagnostics Revenue Market Share, 2016-2027
Figure 33. Turkey Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Prostate Cancer Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 37. OPKO Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Genomic Health Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Abbott Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Beckman Coulter Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Siemens Healthcare Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. bioMeriux Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Roche Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. MDx Health Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. DiaSorin Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Myriad Genetics Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Ambry Genetics Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)